Der p1 Dendritic Cells Promote Regulatory B Cell Induced Immunotolerance Through IL-10/STAT3 in Allergic Rhinitis.

Area of Science:

• Immunology
• Allergy Research
• Immunotherapy

Background:

• Allergic rhinitis (AR) involves immune dysregulation, with impaired regulatory B cell (Breg) function implicated in its pathogenesis.
• Understanding Breg-mediated immune tolerance is crucial for developing effective AR therapies.

Purpose of the Study:

• To investigate the therapeutic potential of Der p1 allergen-modified dendritic cells (DCs) in enhancing Breg-mediated immunotherapy for AR.
• To explore the immunomodulatory mechanisms of Der p1-DCs in AR, focusing on the IL-10/STAT pathway.

Main Methods:

• Detection of Bregs and inflammatory cytokines in AR patients before and after allergen immunotherapy (AIT).
• Induction of Bregs using dust mite gene-derived DCs (Der p1-DCs).
• Treatment of AR mice with Der p1-DCs to assess changes in Bregs, inflammatory markers, and the IL-10/STAT pathway.

Main Results:

• AIT in AR patients led to symptom improvement and restoration of peripheral Bregs and T regulatory cells (Tregs).
• Der p1-DCs induced Bregs that suppressed Th cell proliferation when IL-10 was blocked.
• Der p1-DC treatment in AR mice reduced allergic symptoms, increased IL-10 expression, and decreased STAT3 phosphorylation.

Conclusions:

• AIT promotes immune tolerance in AR through Breg-mediated mechanisms.
• Der p1-modified DCs are effective in inducing Breg differentiation and promoting immune tolerance via the IL-10/STAT3 signaling pathway.